Search

Medtronic PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

88.53 0.06

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

87.11

Max

88.97

Pagrindiniai rodikliai

By Trading Economics

Pajamos

206M

1.5B

Pardavimai

-51M

9.8B

P/E

Sektoriaus vid.

22.599

55.725

Pelnas, tenkantis vienai akcijai

1.45

Dividendų pajamingumas

3.09

Pelno marža

15.16

Darbuotojai

95,000

EBITDA

-682M

2B

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+16.84% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

3.09%

2.25%

Kitas uždarbis

2026-11-17

Kitas dividendų mokėjimo data

2026-10-16

Kita Ex Dividend data

2026-09-25

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.3B

117B

Ankstesnė atidarymo kaina

88.47

Ankstesnė uždarymo kaina

88.53

Naujienos nuotaikos

By Acuity

37%

63%

72 / 339 reitingas Healthcare

Medtronic PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-23 20:03; UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

2026-09-22 23:21; UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

2026-09-21 19:46; UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

2026-09-18 23:06; UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

2026-09-17 23:06; UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

2026-09-16 23:01; UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

2026-09-15 23:01; UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

2026-09-14 23:06; UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

2026-09-11 22:52; UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

2026-09-10 23:56; UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

2026-09-09 22:02; UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

2026-09-08 23:01; UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

2026-09-04 23:16; UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

2026-09-03 23:01; UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2026-09-02 23:06; UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

2026-09-01 23:06; UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

2026-08-31 23:01; UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

2026-08-29 00:06; UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

2026-08-28 23:01; UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

2026-08-27 23:02; UTC

Medtronic PLC shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

2026-08-26 23:02; UTC

Event

Medtronic PLC shares are lower in after-market hours as investors adjust ahead of the Q1 FY2027 earnings announcement, estimating EPS at $1.39.

2026-08-25 23:02; UTC

Medtronic PLC shares are higher in after-market hours amid a positive market response to falling crude oil prices following U.S. sanctions against Iran.

2026-08-24 23:26; UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects concerns over U.S. sanctions on Iran.

2026-08-22 00:02; UTC

Medtronic PLC shares are lower in after-market trading, continuing a decline since Friday's close, despite broader gains in the health care equipment sector.

2026-08-21 23:01; UTC

Medtronic PLC shares are trading lower in after-market hours, though they remain above the 20-day moving average and near the upper end of their one-month range.

2026-08-20 19:56; UTC

News

Medtronic PLC shares are lower today amid broader market pressures and concerns about consumer spending following Walmart's significant decline.

2026-08-19 23:02; UTC

Medtronic PLC shares are lower in after-market trading, showing unusual weakness despite being above its 20-day moving average and near the upper end of its one-month range.

2026-08-18 23:01; UTC

Medtronic PLC shares are slightly higher in after-market hours. The stock remains above its 20-day moving average amid broader market concerns over rising Treasury yields.

2026-08-17 20:07; UTC

Social Media

Medtronic PLC shares are lower amid discussions of a potential AVR acquisition. Broader economic concerns include a significant drop in U.S. retail sales.

2026-08-14 21:51; UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

Akcijų palyginimas

Kainos pokytis

Medtronic PLC Prognozė

Kainos tikslas

By TipRanks

16.84% į viršų

12 mėnesių prognozė

Vidutinis 103.412 USD  16.84%

Aukščiausias 118 USD

Žemiausias 85 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medtronic PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

20 ratings

12

Pirkti

8

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

72 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.